Bayer AG’s (BAYN) Neutral Rating Reiterated at DZ Bank AG
Bayer AG (FRA:BAYN)‘s stock had its “neutral” rating restated by DZ Bank AG in a report released on Tuesday.
Several other analysts also recently weighed in on BAYN. Deutsche Bank AG set a €120.00 ($141.18) price target on Bayer AG and gave the stock a “buy” rating in a research note on Tuesday, April 11th. Sanford C. Bernstein set a €125.00 ($147.06) price target on Bayer AG and gave the stock a “buy” rating in a research note on Wednesday, April 12th. Berenberg Bank set a €118.00 ($138.82) price target on Bayer AG and gave the stock a “buy” rating in a research note on Tuesday, April 18th. J P Morgan Chase & Co restated a “buy” rating on shares of Bayer AG in a research note on Wednesday, April 19th. Finally, BNP Paribas set a €103.00 ($121.18) price target on Bayer AG and gave the stock a “neutral” rating in a research note on Thursday, April 20th. Nine equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Bayer AG presently has a consensus rating of “Buy” and a consensus target price of €120.27 ($141.50).
Bayer AG (BAYN) traded up 0.078% on Tuesday, hitting €106.775. The stock had a trading volume of 1,176 shares. The stock has a 50 day moving average price of €113.17 and a 200 day moving average price of €110.56. Bayer AG has a 1-year low of €85.72 and a 1-year high of €123.83. The company has a market cap of €93.12 billion and a P/E ratio of 18.470.
COPYRIGHT VIOLATION WARNING: This piece was first published by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/08/08/bayer-ags-bayn-neutral-rating-reiterated-at-dz-bank-ag.html.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.